Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ring finger protein, transmembrane 1 (RNFT1) is a membrane-anchored E3 ubiquitin-protein ligase acting in the ERAD pathway, protecting cells from ER stress and apoptosis, with potential relevance to protein misfolding diseases.
Ubiquitin ligase inhibition or modulation would alter substrate ubiquitination and ERAD activity, impacting cell viability under ER stress. Specific drug mechanisms not reported.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ring finger protein, transmembrane 1 (RNFT1).